Namibia vs Niger: Statin use vs. average non-HDL cholesterol levels
Namibia
2.8
in 2018
Niger
2.8
in 2018
Namibia rank
163rd
Niger rank
163rd
Statin use vs. average non-HDL cholesterol levels over time
- Namibia
- Niger
How they compare
Namibia currently reports 2.8 against 2.8 in Niger, a difference of 0.
The two have swapped places 1 time across 39 shared years of data; in 1980 it was Namibia ahead.
Namibia ranks 163rd and Niger ranks 163rd of 191 countries.
Namibia has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Namibia | Niger | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 2.61 | 2.33 | 0.28 | Namibia |
| 1990s | 2.7 | 2.45 | 0.25 | Namibia |
| 2000s | 2.76 | 2.58 | 0.18 | Namibia |
| 2010s | 2.8 | 2.76 | 0.0444 | Namibia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher statin use vs. average non-hdl cholesterol levels, Namibia or Niger?
- Namibia, at 2.8 against 2.8 in Niger as of 2018.
- What is the difference in statin use vs. average non-hdl cholesterol levels between Namibia and Niger?
- 0, with Namibia ahead.
- How many years of comparable data are there for Namibia and Niger?
- 39 years are reported by both, from 1980 to 2018.
- How do Namibia and Niger rank globally for statin use vs. average non-hdl cholesterol levels?
- Namibia ranks 163rd and Niger ranks 163rd of 191 countries.
- Where does this data come from?
- World Health Organization – Global Health Observatory (2026) – with minor processing by Our World in Data, published as Statin use vs. average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.